Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Prilocaine bulk supplier for pharma manufacturers

Prilocaine 10mg/ml, 20mg/ml, 30mg/ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10mg/ml, 20mg/ml, 30mg/ml

Reference Brands: Citanest (EU/UK)

Category: Anaesthetics

Prilocaine is a local anesthetic of the amide type, used in infiltration anesthesia, nerve blocks, and dental procedures. It is less cardiotoxic than lignocaine (lidocaine), making it useful in higher doses.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Prilocaine — third party manufacturing & bulk supply

Prilocaine 10mg/ml, 20mg/ml, 30mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Prilocaine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Prilocaine →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Prilocaine is used as a local anesthetic to produce numbness during minor surgical, dental, and diagnostic procedures. It is also commonly used in combination with lidocaine as a topical anesthetic cream to numb the skin before injections or minor procedures.

Prilocaine is made from the active ingredient Prilocaine hydrochloride, an amide-type local anesthetic that blocks nerve conduction by inhibiting sodium ion channels, resulting in loss of sensation in the targeted area.

The trade names of Prilocaine include Citanest, Citanest Forte, and EMLA (a combination of lidocaine and prilocaine).

Prilocaine is manufactured by several companies such as AstraZeneca, Dentsply Sirona, and Fresenius Kabi.

The generic name of Prilocaine is Prilocaine hydrochloride.

The brand names of Prilocaine are Citanest, Citanest Forte, and EMLA.

Prilocaine is manufactured in the United States, the United Kingdom, and various EU countries by GMP-certified pharmaceutical manufacturers.

Related Products

Sufentanil Citrate

Strength:
50 mcg/mL, 100 mcg/mL, 15 mcg

Form: Tablet / Injection

Reference Brands: Sufenta (USA/EU), Dsuvia (USA/EU)

View Details
Pancuronium Bromide

Strength:
1 mg/mL, 2 mg/mL

Form: Injection

Reference Brands: Pavulon (USA/EU)

View Details
Dyclonine Hydrochloride

Strength:
0.5% w/v, 1% w/v

Form: topical solution/ lozenges / sprays

Reference Brands: Sucrets Complete (USA)

View Details
Droperidol

Strength:
2.5 mg/mL , 5 mg/mL

Form: Injection

Reference Brands: Droleptan (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.